Document is current
Any future updates will be listed below
-
Authors
Rupp, Levi J.
Schumann, Kathrin
Roybal, Kole T.
Gate, Rachel E.
Ye, Chun J.
Lim, Wendell A.
Marson, Alexander
- License Information
-
More Information
Article History
Received: 20 April 2016
Accepted: 28 February 2017
First Online: 7 April 2017
Competing Interests
: A patent has been filed on the use of Cas9 RNPs to edit the genome of human primary T cells (A.M., K.S.). A.M. serves as an advisor to Juno Therapeutics and PACT Therapeutics and the Marson lab has received sponsored research support from Juno Therapeutics and Epinomics. L.J.R. is an employee of Cell Design Labs, K.T.R. is an advisor to Cell Design Labs, and W.A.L. is a founder of Cell Design Labs and a member of its scientific advisory board. A.M. is an advisor to Juno Therapeutics.
